Abstract
The standard of care for osteoporosis is changing amid questions about the long-term safety and efficacy of curren drugs for preventing and treating osteoporosis. This article provides a guide for evidence-based treatment, but not over-treatment, as well as the selection and duration of available drug therapies.
MeSH terms
-
Bone Density Conservation Agents / therapeutic use
-
Humans
-
Life Style
-
Osteoporosis / diagnosis*
-
Osteoporosis / etiology
-
Osteoporosis / therapy*
-
Osteoporotic Fractures / etiology
-
Osteoporotic Fractures / prevention & control*
-
Risk Factors
-
Risk Reduction Behavior
Substances
-
Bone Density Conservation Agents